Navigation Links


ATCC Supporting Zika Virus Research

2/5/2016
MANASSAS, Va. , Feb. 5, 2016 ATCC, the premier global biological materials resource and standards organization, is poised to assist the medical and life science researchers that are working to address the evolving concerns around Zika Virus infection.   CDC website . --> CDC website . --> Zika virus is a single-stranded RNA virus of the Flaviviridae fam... [Comments]

Study Explores the Role of Medical Affairs in Supporting a New Product Launch in the Oncology Therapeutic Area

2/5/2016
CHAPEL HILL, N.C. , Feb. 5, 2016  In the pharmaceutical industry the medical affairs function plays a key role for a host of launch activities including the identification and engagement of key thought leaders. The importance of this launch activity is especially high in the oncology therapeutic area where most treating physicians are specialists. Best Practices and the... [Comments]

2-1-1 San Diego and CIE San Diego Integrate to Improve Access to Community Services

2/5/2016
SAN DIEGO , Feb. 5, 2016 On Thursday, February 11, 2-1-1 San Diego , the region's trusted information source for community, health and disaster services, and the Community Information Exchange (CIE San Diego) will integrate to enhance care coordination and service delivery for the community to better connect people to the services they need and to better connect... [Comments]

Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa

2/5/2016
SAN FRANCISCO , February 5, 2016 Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, announced that it has requested Rare Pediatric Disease Designation (RPDD) from the US Food and Drug Administration (FDA) for treating retinitis pigmentosa (RP) with MANF. MANF w... [Comments]

Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed

2/5/2016
SYDNEY , Feb. 5, 2016 Australian-US drug discovery and development company, Novogen Limited (ASX:NRT; NASDAQ: NVGN ), announced today the appointment of a new Chairman, Mr John O'Connor , and new Deputy Chairman, Mr Bryce Carmine , effective immediately. James Garner , has also been formally appointed to the Board as an Executive Director and former Acting CEO, Mr Iain... [Comments]

Writing Effective SOPs for CLIA and FDA Regulated Companies Now on Morf Playbook for Mobile Devices and PCs

2/4/2016
San Francisco, CA (PRWEB) February 04, 2016 Morf Media Inc ., shaping the future of enterprise talent development and compliance training, today announced an interactive FDA compliance training course, Writing Effective SOPs (Standard Operating Procedures) on Morf Playbook™. The RAPS (R... [Comments]

U.S. FDA Acknowledges Receipt of Resubmission of Shire's New Drug Application for Lifitegrast for Dry Eye Disease in Adults

2/4/2016
LEXINGTON, Massachusetts , February 4, 2016 - New FDA action date of July 22, 2016   --> - New FDA action date of July 22, 2016   --> - New FDA action date of July 22, 2016   - Lifitegrast has the potential to be the only product approved in the U.S. in the past decade indicated for the treatment of signs and symptoms of... [Comments]

Sangamo BioSciences Announces Presentation At The Leerink Partners 5th Annual Global Healthcare Conference

2/4/2016
RICHMOND, Calif. , Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the leader in therapeutic genome editing, announced today that Edward Lanphier , Sangamo's president and chief executive officer, will provide an update on the progress of Sangamo's ZFP Therapeutic ® development programs and an overview of the company's business strategy at 2:40 pm ET on Th... [Comments]

Shimadzu Scientific Instruments Announces Product Showcases, Live Demos, Posters and Presentations at Pittcon 2016

2/4/2016
(PRWEB) February 04, 2016 Shimadzu Scientific Instruments will showcase several new products, including its latest GC-MS and triple quad LC-MS, host live demos and poster sessions, and present on the analysis of mycotoxins and medical cannabis at the Pittcon 2016 conference and exhibition. Th... [Comments]

Noblis and Noblis NSP Staff to Present at BloomCon Cybersecurity Conference

2/4/2016
Falls Church, VA (PRWEB) February 04, 2016 BloomCon, a first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes place February 5-6 at the University’s student center, Kehr Union, located in Bloomsburg, PA. The two-day event features 20+ speakers a... [Comments]

[next]
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
(Date:1/28/2016)... 2016 Synaptics (NASDAQ: SYNA ), a leading developer ... quarter ended December 31, 2015. --> ... 2016 increased 2 percent compared to the comparable quarter last year ... 2016 was $35.0 million, or $0.93 per diluted share. ... the first quarter of fiscal 2016 grew 9 percent over the ...
Breaking Biology News(10 mins):
RABBIT ANTI TRANSFERRIN RECEPTOR...
ANTI FLAG EP CL VEC...
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
Biology Products:
(Date:2/4/2016)... 2016 Beike Biotechnology, the Shenzhen ... a ceremony in late 2015 to mark their successful ... 2016. --> --> ... Personalized Cell Therapy" was hosted by the Shenzhen Cell ... subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... be held February 8-9, 2016, at the Waldorf Astoria ... & Healthcare Conference, taking place in New ... James Sapirstein , Chief Executive Officer of ContraVir, will ...
(Date:2/4/2016)... , February 4, 2016 Strasbourg, ... (ABL), Inc. --> Strasbourg, France , ... --> PharmaVentures is pleased to announce that it acted ... biopharmaceutical manufacturing unit in Strasbourg, France , ... --> --> Transgene (Euronext: TNG), ...
(Date:2/3/2016)... -- With the growing need for better therapeutics, and ... such as monoclonal antibodies, recombinant protein therapeutics and ... are in high demand. Conventionally expression systems were ... of these therapeutics. However, due to issues with ... approaches and novel expression systems are currently being ...
Breaking Biology Technology: